Fig. 3From: Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysisModeled projections of asylum seekers’ LTBI prevalence as a function of estimated TB incidence in their countries of origin. Colored data points show IGRA-based estimates of LTBI prevalence among asylum seekers obtained from studies in four European countries (Germany, Italy, Sweden, and The Netherlands) with error bars denoting 95% confidence intervals. Grey lines show fitted projections of LTBI prevalence by country-of-origin TB incidence for 100 randomly selected model iterationsBack to article page